Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Shares Outstanding (Weighted Average) (2022 - 2025)

Envoy Medical's Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $21.5 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 15.61% year-over-year to $21.5 million; the TTM value through Sep 2025 reached $21.5 million, up 15.61%, while the annual FY2024 figure was $18.8 million, 52.83% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $21.5 million at Envoy Medical, up from $21.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $42.5 million in Q1 2022 and bottomed at $10.1 million in Q2 2023.
  • The 4-year median for Shares Outstanding (Weighted Average) is $18.6 million (2024), against an average of $19.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) crashed 76.18% in 2023 before it skyrocketed 83.75% in 2024.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $10.1 million in 2022, then rose by 21.46% to $12.3 million in 2023, then skyrocketed by 52.83% to $18.8 million in 2024, then grew by 14.54% to $21.5 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Shares Outstanding (Weighted Average) are $21.5 million (Q3 2025), $21.4 million (Q2 2025), and $21.3 million (Q1 2025).